This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In Plant-e v Bioo the UPC provided its first decision addressing the doctrine of equivalents in patentinfringement proceedings ( UPC_CFI_239/2023 ). Beyond this high-level guidance from Article 2 of the Protocol, the UPC faces the challenge of developing its own approach to assessing infringement by equivalence.
by Dennis Crouch The following is my patentlaw exam from this past semester. EL’s patent eventually issued in October 2023, with the claim as listed above. Question 4 : Based on these facts: Can EL make a case for patentinfringement? What do you think?
by Dennis Crouch The Supreme Court is set to consider several significant patentlaw petitions addressing a range of issues from the application of obviousness standards, challenges to PTAB procedures, interpretation of joinder time limits IPR, to the proper scope patent eligibility doctrine. Realtime Data v. Fortinet, No.
This post will focus on another key issue from the case – the relevance of logos in design patentinfringement analysis. 2013) (“[The accused infringer] has in fact scrupulously avoided such confusion by choosing a starkly different logo that it prominently displays on its [products] and on all its sales and marketing literature.”).
Nu Tsai Capital LLC, 2023-1146, 2023 WL 2054370, F.4th Lite-Netics therefore could not be enjoined, using the tortious interference/defamation torts, from suggesting that HBL is a patentinfringer, that HBL has copied Lite-Netics’s lights, or that HBL customers might be sued. 4th - (Fed.
Nu Tsai Capital, LLC, [2023-1146] (February 17, 2023), the Federal Circuit vacated a preliminary injunction against Lite-Netics patent-related speech, holding that the district court abused its discretion. Patent Nos. In Lite-Netics, LLC v.
Here is our recap of last week’s top IP developments including summaries of the posts on IPO’s patent application rejection of HIV drug Dolutegravir, another judgement in the long-running Section 3(k) saga, this time on the patentability of business methods and the DHC IPD’s Annual Report 2023-24. Anything we are missing out on?
The Department for Promotion of Industry and Internal Trade, Ministry of Commerce and Industry on the 22nd August, 2023 published “The Draft Patents (Amendment), Rules, 2023” (Draft Rules). Patent applications and prosecution thereof is currently governed under the Patents Rules 2003 (2003 Rules).
1, 2023)( John A. Kronstadt), the Court granted the Defendant’s motion to dismiss Plaintiff’s indirect patentinfringement claims for failure to sufficiently allege Defendant “made” the accused product. In Bell Semiconductor, LLC v. Omnivision Technologies, Inc. , 8-22-cv-01979 (CDCA Mar.
Back in 2021, Bel Power sued Monolithic for patentinfringement in Waco Texas. But, patentlaw is different. In the late 1800s Congress created a special venue statute for patent cases that has stuck despite changes in the general law. Trial is set for May 12, 2023. by Dennis Crouch. 21-cv-00655.
On June 1, 2021, the Fourth Amendment to the Chinese PatentLaw became effective. An important part of the amendment is the introduction by Article 76 of the patent linkage system in China – a system for litigation of drug patents prior to market entry of generics, similar to that provided by the Hatch Waxman Act in the US.
Any person other than the patent owner may file a petition for an IPR, challenging the patentability of any claim of an issued patent. In general, a petition cannot be filed until at least nine months after the grant of the patent. The district court held that the plaintiffs had standing but granted the motion to dismiss.
10th Mahamana Malviya National Moot Court Competition by Law School, Banaras Hindu University [Varanasi, March 24-26, 2023]. We informed our readers of the 10th Mahamana Malaviya National Moot Court Competition concerning a moot problem on patentslaw and incremental innovations. On 10 January, 2023 (Delhi High Court).
Second, they must be nonobvious over the prior art (similar inventions that existed before the patent application was filed and are known to the public). 20, 2023), the Federal Circuit Court of Appeals clarified that a key Supreme Court case decided in 2007, KSR International Co. The patent covered a design for a vehicle front fender.
The Delhi High Court, on 24th April, passed an order that our patentlaw enthusiast readers will be very interested in! coverage Genus and species patents Coverage v. Vee Excel Drugs 2023:DHC:2265 ], ‘presumption of validity of a patent’ is still argued and ruled upon in 2024. Hoffmann LA Roche v.
We are pleased to bring to you this book review of David Llewelyn, Gladys Tan, Estelle Moh Huixuan and Ng Hui Ming’s ‘Modern Law of Copyright in Singapore’, (SAL Academy Publishing, 2023) by Prashant Reddy T. Image from here Book Review: Modern Law of Copyright in Singapore By Prashant Reddy T.
by Dennis Crouch The Federal Circuit recently vacated a jury verdict of non-infringement in the long-running design patent dispute between outdoor apparel companies Columbia Sportswear and Seirus Innovative Accessories. Columbia Sportswear North America, Inc. Seirus Innovative Accessories, Inc. , 2021-2299, — F.4th
patentlaws. 1, 2023) provides an exception to the general rule. In its decision, the Federal Circuit held it lacked jurisdiction over Teradata’s appeal because the patentinfringement allegations only been raised in a permissive counterclaim. The court’s recent decision in Teradata Corp.
2023 WL 8634803, No. 13, 2023) Vericool alleged that Igloo falsely claimed that its “Recool” biodegradable cooler was the first of its kind. Vericool didn’t help its claim by stating in its papers that “[t]o vigorously defend its patent, Vericool World had to bring this claim.” Vericool World LLC v. Igloo Prods. Zobmondo Ent.
As the Supreme Court’s 2023 year draws to a close, the court has denied certiorari in the vast majority of IP related cases, with the Dewberry trademark damages case left as the only IP case granted certiorari. Seven petitions remain undecided and the court will pick them up again when it begins the 2024 term in late September.
But what about AI’s potential ability to safeguard and protect against patentinfringement, while simultaneously being used to ensure greater ideation success before patents are filed? It turns out AI has incredible potential to serve as a primary guardian of patents.
On June 1, 2021, the Fourth Amendment to the Chinese PatentLaw became effective. An important part of the amendment is the introduction by Article 76 of the patent linkage system in China – a system for litigation of drug patents prior to market entry of generics, similar to that provided by the Hatch Waxman Act in the US.
Highlights of the Week Hot-Tubbing in Indian IP Litigation: Delhi High Court Issues Directives in High-Stakes PatentInfringement Case Image from [link] here Recently, the DHC issued directives regarding expert evidence in the Perjeta patent litigation. Justice Prathiba M Singh’s Commentary on patentslaw released.
Although somewhat slow thus far, there is some potential that 2023 will turn out to be a major year for Supreme Court patentlaw jurisprudence. The Court is holding conference on January 6, 2023 to consider the fate of Juno. by Dennis Crouch. Sanofi , No. 21-757, with merits briefs due beginning December 27, 2022.
Fish & Richardson is proud to announce the elevation of 15 attorneys to principals at the firm, effective January 1, 2023. Our 2023 principal class represents the breadth of talent and diversity that we strive for at Fish,” said Kristine McKinney , chief operating officer of Fish. Joel Henry (Washington, D.C.), in history.
As we dive into the 10th post of this series since June 2023, don’t forget to check out the previously explored pages of Junes , Julys , Augusts , Septembers , Octobers , November , Decembers , Januarys , and Februarys. There’s a reason why it’s only once in the life of Indian patentlaw that a CL was granted, check Prof.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content